In breast cancer survivors participating in a survivorship study, follow-up visits with an oncologist as compared to other types of clinicians are perceived to minimize stress around the visit, decrease worrying about cancer, and improve the self-perceived impact of follow-up visits on cancer survival, according to research published online Dec. 12 in the Journal of Clinical Oncology.
Erica L. Mayer, M.D., M.P.H., of the Dana-Farber Cancer Institute in Boston, and colleagues analyzed data from 218 breast cancer survivors (median age, 57.5 years) who participated in a general survivorship study and completed an extra breast cancer-specific questionnaire.
The purpose of the study was to determine survivors' comfort with different clinician types and telephone/Internet-based virtual visits as components of survivorship care. Perceptions of the impact of follow-up visits on survival, level of worry about cancer, and stress related to the visit were evaluated for each clinician type and for virtual visits.
Read the full story at: http://www.physiciansbriefing.com/Article.asp?AID=659695
Sources: Health Day; Journal of Clinical Oncology
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
Creating Equitable Cancer Care for Americans of Asian and Pacific Islander Heritage
October 15th 2024Naoto T. Ueno, MD, PhD, FACP, of the University of Hawai’I Cancer Center outlines the underrepresentation in clinical trials, the lack of permanent medical oncologists, and issues of trust affecting care for the populations living in Hawaii.
Read More